Cargando…

Time and cost of administering COVID-19 mRNA vaccines in the United States

In early 2020, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak a global pandemic. In response, two novel messenger RNA (mRNA)-based vaccines: mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) were rapidly developed. A thorough understanding of the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yarnoff, Benjamin, Bodhaine, Steven, Cohen, Ed, Buck, Philip O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828150/ https://www.ncbi.nlm.nih.gov/pubmed/34613860 http://dx.doi.org/10.1080/21645515.2021.1974289

Ejemplares similares

Research and Nonresearch Industry Payments for COVID-19 mRNA Vaccines in the United States
por: Murayama, Anju, et al.
Publicado: (2023)

Assessment of the Costs of Implementing COVID-19 Vaccination Clinics in 34 Sites, United States, March 2021
por: Yarnoff, Benjamin O., et al.
Publicado: (2022)

Brief review of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

Myocarditis following COVID-19 mRNA vaccination
por: Abu Mouch, Saif, et al.
Publicado: (2021)

Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019
por: Patterson, Brandon J., et al.
Publicado: (2021)

Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic
por: Roberts-McCarthy, Erin, et al.
Publicado: (2023)

Patient flow time data of COVID-19 vaccination clinics in 23 sites, United States, April and May 2021
por: Cho, Bo-Hyun, et al.
Publicado: (2023)

Incidence and costs of injuries to children and adults in the United States
por: Zonfrillo, Mark R., et al.
Publicado: (2018)

Human Papillomavirus Vaccination Over Time in Heterosexual and Sexual Minority Adults in the United States
por: Chan, Chloe, et al.
Publicado: (2022)

Response to mRNA COVID-19 vaccination in three XLA patients
por: Squire, J.D., et al.
Publicado: (2022)

Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
por: Haq, Hannah N., et al.
Publicado: (2022)

Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive
por: Kontopoulou, Konstantina, et al.
Publicado: (2021)

Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
por: Advani, Pooja, et al.
Publicado: (2021)

Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site
por: Myles, Ian A, et al.
Publicado: (2021)

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
por: LaTourette, Philip C., et al.
Publicado: (2020)

Trends in Tattoo-Related Google Search Data in the United States: Time-Series Analysis
por: Kiszla, Benjamin Matthew, et al.
Publicado: (2022)

Development and validation of a COVID-19 vaccine hesitancy scale for adults in the United States
por: Hrin, Matthew L., et al.
Publicado: (2022)

Humoral immune response to COVID-19 mRNA vaccination in relation to selenium status
por: Demircan, Kamil, et al.
Publicado: (2022)

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
por: Toljan, Karlo, et al.
Publicado: (2022)

Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine
por: MITRI, Fouad, et al.
Publicado: (2021)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with immune thrombocytopenia
por: Mori, Akio, et al.
Publicado: (2022)

Improvement of otologic symptoms associated with mRNA COVID-19 vaccines with corticosteroid treatment
por: Ma, Marek
Publicado: (2023)

Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States
por: Mitchell, Aaron P, et al.
Publicado: (2012)

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
por: Curran, Desmond, et al.
Publicado: (2019)

Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study
por: Ku, Jennifer H., et al.
Publicado: (2023)

Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents
por: June Choe, Young, et al.
Publicado: (2022)

Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights
por: Selvaraj, Gurudeeban, et al.
Publicado: (2021)

Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults
por: Simone, Anthony, et al.
Publicado: (2022)

Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome
por: Deniz, Adnan, et al.
Publicado: (2023)

Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
por: Hsieh, Yuli Lily, et al.
Publicado: (2022)

Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods
por: Lin, Kangyang, et al.
Publicado: (2023)

BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
por: Vizcarra, Pilar, et al.
Publicado: (2021)

Myocarditis following mRNA vaccination against SARS-CoV-2, a case series
por: King, William W., et al.
Publicado: (2021)

Serological response to a single dose of a SARS-CoV-2 mRNA vaccine
por: Ramos, Angélica, et al.
Publicado: (2021)

Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2
por: Lee, Kuo-Ming, et al.
Publicado: (2023)

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
por: López-Cortés, Luis F., et al.
Publicado: (2023)

Use of Random Domain Intercept Technology to Track COVID-19 Vaccination Rates in Real Time Across the United States: Survey Study
por: Sargent, Rikki H, et al.
Publicado: (2022)

Reports of Expired Live Attenuated Influenza Vaccine Being Administered — United States, 2007–2014
por: Haber, Penina, et al.
Publicado: (2014)

Rural community pharmacists’ ability and interest in administering COVID-19 vaccines in the Southern United States
por: Carpenter, Delesha M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bu2rkguejh4i957v96bbe67jki